GTHKF yields 1000000.00% · PFE yields 6.13%● Live data
📍 GTHKF pulled ahead of the other in Year 1
Combined, GTHKF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GTHKF + PFE for your $10,000?
Genting Hong Kong Limited, an investment holding company, engages in the operation of passenger cruise ships in the Asia Pacific, the United States, Europe, and internationally. It operates through three segments: Cruise and Cruise-Related Activities, Shipyard, and Non-Cruise Activities. The company primarily operates cruise ships under the Star Cruises, Dream Cruises, and Crystal Cruises brands; and MV Werften and Lloyd Werft shipyards, as well as docking facilities. It also operates Resorts World Manila, an integrated resort in the Philippines. In addition, the company is involved in the bareboat chartering business; operation and management of hotels; development of hospitality facilities; development and sale of commercial properties; lease of properties; provision of property management, catering, and management services; and operation of entertainment business. Further, it provides cruise sales, marketing, and support services; newbuilding, conversion, and maintenance services for ships; travel agency services; and owns vessels under construction. The company was formerly known as Star Cruises Limited and changed its name to Genting Hong Kong Limited in 2010. Genting Hong Kong Limited was incorporated in 1993 and is headquartered in Tsim Sha Tsui, Hong Kong.
Full GTHKF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.